Journal article : Review
Inflammasome-mediated immunogenicity of clinical and experimental vaccine adjuvants
- Abstract:
-
In modern vaccines, adjuvants can be sophisticated immunological tools to promote robust and long-lasting protection against prevalent diseases. However, there is an urgent need to improve immunogenicity of vaccines in order to protect mankind from life-threatening diseases such as AIDS, malaria or, most recently, COVID-19. Therefore, it is important to understand the cellular and molecular mechanisms of action of vaccine adjuvants, which generally trigger the innate immune system to enhance ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- MDPI Publisher's website
- Journal:
- Vaccines Journal website
- Volume:
- 8
- Issue:
- 3
- Article number:
- 554
- Publication date:
- 2020-09-22
- Acceptance date:
- 2020-09-18
- DOI:
- EISSN:
-
2076-393X
- Pmid:
-
32971761
Item Description
- Language:
- English
- Keywords:
- Subtype:
- Review
- Pubs id:
-
1134993
- Local pid:
- pubs:1134993
- Deposit date:
- 2020-10-10
Terms of use
- Copyright holder:
- Reinke et al.
- Copyright date:
- 2020
- Rights statement:
- ©2020 by the authors. Licensee MDPI, Basel, Switzerland.
- Notes:
- This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
If you are the owner of this record, you can report an update to it here: Report update to this record